Limin Li
Lushan Road No. 14
Changsha, 410081, China
Changsha, 410081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 31, 2025
Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10.
Journal: Cell death & disease
Published: November 12, 2024
Eosinophil-Associated Genes are Potential Biomarkers for Hepatocellular Carcinoma Prognosis.
Journal: Journal of Cancer
Published: February 07, 2024
Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs.
Journal: Biomaterials advances
Published: October 29, 2021
AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.
Journal: Theranostics
Published: January 26, 2018
Transcription factor AP-2β suppresses cervical cancer cell proliferation by promoting the degradation of its interaction partner β-catenin.
Journal: Molecular carcinogenesis
Published: August 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026